How the pharma industry is stepping up to Covid-19 for a brighter, healthier future
Small molecule manufacturer Toronto Research Chemicals helps drug formulators eliminate impurities in the development pipeline, ensuring safer products make it to market
Precious metal catalysts are key to pharma but subject to market forces that make reliance on supply a double-edged sword.
Revolutionising pharma with next-generation technology to optimise and accelerate drug production processes
The annual Pharma Integrates event facilitates conversation and collaboration to drive future innovation and improve patient outcomes worldwide
Parent firm will then sell on three manufacturing sites to Novo Nordisk to boost capacity for diabetes and weight loss drugs
Six month gap in vetting people with access to high-risk chemicals means potential threats may have been missed
The hepatitis C drug that made waves when first launched – quicker to work and with fewer side effects than existing drugs, but it came with a hefty price tag
Source: © Shutterstock